Application 070885
- Type
- ANDA
- Sponsor
- ACTAVIS MID ATLANTIC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | BETAMETHASONE DIPROPIONATE | BETAMETHASONE DIPROPIONATE | CREAM;TOPICAL | EQ 0.05% BASE | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0472-0380 | Betamethasone Dipropionate | Betamethasone Dipropionate | Actavis Pharma, Inc. | ANDA | Current |
| 0472-0380 | Betamethasone Dipropionate | Betamethasone Dipropionate | Actavis Pharma, Inc. | ANDA | Current |
| 50090-1839 | Betamethasone Dipropionate | Betamethasone Dipropionate | A-S Medication Solutions | ANDA | Current |
| 50090-1839 | Betamethasone Dipropionate | Betamethasone Dipropionate | A-S Medication Solutions | ANDA | Current |
| 50090-1839 | Betamethasone Dipropionate | Betamethasone Dipropionate | A-S Medication Solutions | ANDA | Current |
| 50090-1839 | Betamethasone Dipropionate | Betamethasone Dipropionate | A-S Medication Solutions | ANDA | Current |
| 50090-2182 | Betamethasone Dipropionate | Betamethasone Dipropionate | A-S Medication Solutions | ANDA | Current |